These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10085790)

  • 1. Effect of valproic acid on the pharmacokinetic profile of oxcarbazepine in the rat.
    Matar KM; Nicholls PJ; Bawazir SA; al-Hassan MI; Tekle A
    Pharm Acta Helv; 1999 Feb; 73(5):247-50. PubMed ID: 10085790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
    Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
    Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
    Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
    Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Effects of Ketoconazole and Voriconazole on the Pharmacokinetics of Oxcarbazepine and Its Main Metabolite MHD in Rats by UPLC-MS-MS.
    Chen X; Gu E; Wang S; Zheng X; Chen M; Wang L; Hu G; Cai JP; Zhou H
    J Chromatogr Sci; 2016 Mar; 54(3):334-42. PubMed ID: 26499119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine does not interact with cimetidine in healthy volunteers.
    Keränen T; Jolkkonen J; Klosterskov-Jensen P; Menge GP
    Acta Neurol Scand; 1992 Apr; 85(4):239-42. PubMed ID: 1585795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
    Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
    Keränen T; Sorri A; Moilanen E; Ylitalo P
    Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.
    Antunes Nde J; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Tozatto E; Marques MP; Lanchote VL
    Eur J Clin Pharmacol; 2016 Feb; 72(2):195-201. PubMed ID: 26514967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid micromethod for simultaneous measurement of oxcarbazepine and its active metabolite in plasma by high-performance liquid chromatography.
    Matar KM; Nicholls PJ; al-Hassan MI; Tekle A
    J Clin Pharm Ther; 1995 Aug; 20(4):229-34. PubMed ID: 8557788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1999 Apr; 21(2):175-81. PubMed ID: 10217337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine.
    Battino D; Croci D; Granata T; Bernardi G; Monza G
    Ther Drug Monit; 1992 Oct; 14(5):376-9. PubMed ID: 1448844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic and morphologic effects of valproic acid and oxcarbazepine on rat uterine and ovarian cells.
    Cansu A; Erdogan D; Serdaroglu A; Take G; Coskun ZK; Gurgen SG
    Epilepsia; 2010 Jan; 51(1):98-107. PubMed ID: 19674047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma level monitoring of oxcarbazepine in epileptic patients.
    González-Esquivel DF; Ortega-Gavilán M; Alcántara-López G; Jung-Cook H
    Arch Med Res; 2000; 31(2):202-5. PubMed ID: 10880728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of interaction between oxcarbazepine and erythromycin.
    Keränen T; Jolkkonen J; Jensen PK; Menge GP; Andersson P
    Acta Neurol Scand; 1992 Aug; 86(2):120-3. PubMed ID: 1414219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.